Cytomegalovirus Colitis Following Azacitidine Therapy
| dc.contributor.author | Khan, Rajal | |
| dc.contributor.author | Pudkin, Pam | |
| dc.contributor.author | Grewal, Kuljit | |
| dc.contributor.author | Leonard, Jennifer | |
| dc.contributor.author | Hamodat, Mowafak | |
| dc.contributor.author | Hutchinson, Jim | |
| dc.contributor.author | Daley, Peter | |
| dc.date.issued | 2011 | |
| dc.description.abstract | The present report describes the first recognized case of cytomegalovirus (CMV) colitis following azacitidine therapy. A 66-year-old woman with myelodysplastic syndrome developed CMV colitis, which responded to treatment with ganciclovir. Currently, patients receiving azacitidine do not undergo CMV testing, or receive prophylaxis or CMV-free blood products; however, this policy needs to be revised. | |
| dc.description.note | Memorial University Open Access Author's Fund | |
| dc.format.issue | 3 | |
| dc.format.volume | 22 | |
| dc.identifier.issn | 1918-1493 | |
| dc.identifier.uri | http://dx.doi.org/10.1155/2011/616725 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14783/6631 | |
| dc.language.iso | en | |
| dc.publisher | Hindawi Publishing Corporation | |
| dc.relation.uri | http://www.hindawi.com/ | |
| dc.subject | Azacitidine | |
| dc.subject | CMV | |
| dc.subject | Colitis | |
| dc.title | Cytomegalovirus Colitis Following Azacitidine Therapy | |
| dc.type | article | |
| mem.campus | St. John's Campus | |
| mem.department | Medicine | |
| mem.divisions | FacMed | |
| mem.fullTextStatus | public | |
| mem.idNumber | 10.1155/2011/616725 | |
| mem.isPublished | pub | |
| mem.pageRange | e21-e23 | |
| mem.refereed | True | |
| oaire.citation.issue | Canadian Journal of Infectious Diseases and Medical Microbiology |
Files
Original bundle
1 - 1 of 1